Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-05-08 @ 6:18 PM
Study NCT ID:
NCT04985604
Status:
TERMINATED
Last Update Posted:
2025-10-02
First Post:
2021-06-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
Sponsor:
Day One Biopharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
| None | Solid Tumor | View |
| None | CRAF Gene Amplification | View |
| None | RAF1 Gene Amplification | View |
| None | BRAF Gene Fusion | View |
| None | BRAF Fusion | View |
| None | CRAF Gene Fusion | View |
| None | CRAF Fusion | View |
| None | RAF1 Gene Fusion | View |
| None | RAF1 Fusion | View |
| None | Thyroid Cancer, Papillary | View |
| None | Spitzoid Melanoma | View |
| None | Pilocytic Astrocytoma | View |
| None | Pilocytic Astrocytoma, Adult | View |
| None | Non Small Cell Lung Cancer | View |
| None | Non-Small Cell Adenocarcinoma | View |
| None | Colorectal Cancer | View |
| None | Pancreatic Acinar Carcinoma | View |
| None | Spitzoid Malignant Melanoma | View |
| None | Bladder Cancer | View |
| None | Bladder Urothelial Carcinoma | View |
| None | MAP Kinase Family Gene Mutation | View |
| None | RAF Mutation | View |